Patent classifications
C07D475/12
HOLE TRANSPORT PROMOTING MATERIAL, MATERIAL FOR LIGHT RECEIVING ELEMENT, CYANO COMPOUND, AND ORGANIC LIGHT RECEIVING ELEMENT
Provided are a material for a light receiving element having excellent hole transport characteristics, and an organic light receiving element using the same.
A material for a light receiving element is used that includes a compound represented by general formula (1) or general formula (2). Ar.sup.2 and Ar.sup.3 are preferably cyano groups. Ar and Ar.sup.5 are preferably cyano groups.
##STR00001##
HOLE TRANSPORT PROMOTING MATERIAL, MATERIAL FOR LIGHT RECEIVING ELEMENT, CYANO COMPOUND, AND ORGANIC LIGHT RECEIVING ELEMENT
Provided are a material for a light receiving element having excellent hole transport characteristics, and an organic light receiving element using the same.
A material for a light receiving element is used that includes a compound represented by general formula (1) or general formula (2). Ar.sup.2 and Ar.sup.3 are preferably cyano groups. Ar and Ar.sup.5 are preferably cyano groups.
##STR00001##
MODULATORS OF TOLL-LIKE RECEPTORS
Provided are modulators of TLRs of Formula II:
##STR00001##
pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
MST1 kinase inhibitor and use thereof
Disclosed is a kinase inhibitor, comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite, or prodrug thereof. Also disclosed are a pharmaceutical composition comprising the kinase inhibitor and uses and methods for inhibiting the activity of one or more tyrosine kinases selected from MST1 and a mutant thereof in a cell or subject and for preventing or treating a disease related to MST1 or a mutant thereof in a subject by using the compound or composition. ##STR00001##
MST1 kinase inhibitor and use thereof
Disclosed is a kinase inhibitor, comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite, or prodrug thereof. Also disclosed are a pharmaceutical composition comprising the kinase inhibitor and uses and methods for inhibiting the activity of one or more tyrosine kinases selected from MST1 and a mutant thereof in a cell or subject and for preventing or treating a disease related to MST1 or a mutant thereof in a subject by using the compound or composition. ##STR00001##
Organic electron transfer mediator and device comprising same
The present invention relates to a novel organic electron-transfer mediator showing an excellent oxidation-reduction potential and a device such as an electrochemical biosensor having improved performance comprising the same.
Organic electron transfer mediator and device comprising same
The present invention relates to a novel organic electron-transfer mediator showing an excellent oxidation-reduction potential and a device such as an electrochemical biosensor having improved performance comprising the same.